AI‑Assisted Prescriptions: A New Chapter in Chronic Care

AI TherapyAI DiagnosticsTelehealth & Remote Care

Imagine never missing a dose because a simple renewal slips through the cracks—now it’s a reality in Utah.

TL;DR
• Utah pilots AI‑assisted prescription renewals for chronic conditions, costing $4 per renewal.
• Physicians review every AI recommendation, ensuring safety and oversight.
• The pilot aims to reduce medication gaps and improve patient continuity of care.

Summary
August AI received approval from Utah's Office of Artificial Intelligence Policy to run a pilot that automates prescription renewals for chronic‑condition patients, with every recommendation reviewed by a Utah‑licensed physician before approval. The program targets routine, non‑controlled drugs for diabetes and cardiovascular disease, aiming to eliminate delays that can leave patients without essential medication.
• $4 per renewal, far below typical primary‑care visit costs.
• AI generates renewal recommendations; physicians retain final authority.
• Stage‑gated rollout requires meeting performance metrics for each drug class.
• Mandatory patient notification, malpractice coverage, and 24‑hour incident response are built into the sandbox.
• August’s models score 100% on the U.S. Medical Licensing Examination and lead on MedQA and MMLU clinical benchmarks.

The pilot operates within Utah's regulatory sandbox, mandating 1,250 physician‑reviewed decisions per drug class before advancing to the next stage. August AI must adhere to sandbox safeguards, including transparent AI involvement notices, specialty malpractice insurance, and a continuous incident response plan, while patients retain standard legal remedies.

August AI positions the service as a cost‑neutral, safety‑first solution: it earns no profit from approved renewals, and declines are routed back to physicians, preserving clinical oversight. The broader August Care offering provides a $29‑monthly membership delivering multilingual, HIPAA‑compliant health assistance, leveraging a large patient‑conversation dataset to refine AI performance over time.

Will AI‑driven renewals become the new standard for chronic disease management, ensuring timely access while safeguarding patient safety?